HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doris Mayr Selected Research

Tumor Biomarkers (Tumor Markers)

1/2023L1-CAM in Mucinous Ovarian Carcinomas and Borderline Tumors: Impact on Tumor Recurrence and Potential Role in Tumor Progression.
9/2011The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
5/2010Expression of the carbohydrate tumor marker Sialyl Lewis a (Ca19-9) in squamous cell carcinoma of the larynx.
5/2010Determination of glycodelin-A expression correlated to grading and staging in ovarian carcinoma tissue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Doris Mayr Research Topics

Disease

101Neoplasms (Cancer)
11/2023 - 04/2003
42Breast Neoplasms (Breast Cancer)
09/2023 - 09/2004
36Ovarian Neoplasms (Ovarian Cancer)
09/2023 - 06/2003
27Carcinoma (Carcinomatosis)
01/2022 - 06/2003
16Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2023 - 01/2011
14Carcinogenesis
09/2023 - 06/2003
13Endometrial Neoplasms (Endometrial Cancer)
08/2023 - 07/2003
11Ovarian Epithelial Carcinoma
01/2022 - 10/2012
10Inflammation (Inflammations)
01/2022 - 06/2003
9Neoplasm Metastasis (Metastasis)
01/2023 - 06/2011
7Fibrosis (Cirrhosis)
01/2022 - 03/2007
6Granulosa Cell Tumor
02/2021 - 01/2008
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2023 - 05/2010
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 03/2016
4Adenocarcinoma
12/2019 - 06/2003
4Endometriosis
02/2018 - 11/2012
3Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 06/2003
3Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2019 - 07/2007
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2015 - 08/2011
3Pre-Eclampsia (Preeclampsia)
09/2008 - 02/2007
3HELLP Syndrome
09/2008 - 02/2007
2Disease Progression
10/2023 - 04/2015
2Rupture
07/2023 - 04/2013
2Microsatellite Instability
11/2021 - 07/2021
2Vulvar Neoplasms (Vulvar Cancer)
03/2021 - 12/2020

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
11/2023 - 07/2006
18ParaffinIBA
08/2020 - 09/2004
13Hormones (Hormone)IBA
10/2022 - 05/2009
12Estrogen ReceptorsIBA
09/2023 - 11/2012
11Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2012
11Mucin-1 (CA 15-3 Antigen)IBA
02/2021 - 07/2007
9CateninsIBA
01/2023 - 07/2013
8DNA (Deoxyribonucleic Acid)IBA
01/2023 - 07/2006
8Formaldehyde (Formol)FDA Link
07/2020 - 09/2004
7GTP-Binding Proteins (G-Protein)IBA
09/2023 - 11/2012
7AntibodiesIBA
01/2019 - 02/2009
7Monoclonal AntibodiesIBA
06/2012 - 06/2003
6Small Interfering RNA (siRNA)IBA
11/2021 - 03/2013
6AntigensIBA
10/2018 - 07/2007
6Cadherins (E-Cadherin)IBA
10/2018 - 09/2004
6CarbohydratesIBA
01/2018 - 05/2010
5EnzymesIBA
11/2021 - 07/2007
5Galectins (Galectin)IBA
02/2021 - 05/2012
5Protein Isoforms (Isoforms)IBA
01/2021 - 10/2012
5LigandsIBA
01/2021 - 10/2015
5Estrogens (Estrogen)FDA Link
01/2021 - 09/2008
5Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
08/2020 - 01/2013
5EpitopesIBA
02/2020 - 05/2009
5Galectin 1 (LGALS1)IBA
10/2019 - 07/2007
5Messenger RNA (mRNA)IBA
01/2019 - 09/2004
5Oncogene Proteins (Oncogene Protein)IBA
10/2018 - 03/2009
4Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
09/2023 - 10/2012
4Co-Repressor ProteinsIBA
09/2023 - 01/2019
4progesterone receptor AIBA
02/2023 - 11/2007
4Tumor Biomarkers (Tumor Markers)IBA
01/2023 - 05/2010
4Histones (Histone)IBA
11/2021 - 02/2017
4Thyroid HormonesIBA
08/2021 - 10/2012
4Interleukin-1 (Interleukin 1)IBA
11/2020 - 08/2014
4Chemokine CCL22IBA
12/2019 - 11/2011
4FSH Receptors (FSH Receptor)IBA
10/2019 - 01/2013
41-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
06/2017 - 07/2007
4CA-19-9 Antigen (CA 19-9 Antigen)IBA
01/2017 - 07/2007
4GlycodelinIBA
12/2013 - 02/2009
3Sirtuin 1IBA
01/2022 - 08/2020
3Lysine (L-Lysine)FDA Link
11/2021 - 03/2020
3Immune Checkpoint InhibitorsIBA
11/2021 - 05/2019
3histone H3 trimethyl Lys4IBA
11/2021 - 03/2020
3Bromodeoxyuridine (BrdU)IBA
03/2021 - 03/2020
3Vitamin DFDA LinkGeneric
10/2020 - 10/2012
3Calcitriol Receptors (Calcitriol Receptor)IBA
10/2020 - 02/2012
3Indicators and Reagents (Reagents)IBA
12/2019 - 11/2016
3ProstaglandinsIBA
10/2019 - 01/2018
3progesterone receptor BIBA
01/2019 - 11/2012
3Carrier Proteins (Binding Protein)IBA
03/2018 - 06/2017
3Galectin 3 (LGALS3)IBA
10/2017 - 02/2011
3Sialyl Lewis X AntigenIBA
01/2017 - 07/2007
3GonadotropinsIBA
08/2014 - 01/2012
3Glycoproteins (Glycoprotein)IBA
07/2013 - 01/2007
3LH Receptors (LH Receptor)IBA
01/2013 - 05/2011
3Peptides (Polypeptides)IBA
10/2012 - 02/2009
2Capsules (Microcapsules)IBA
08/2023 - 07/2023
2Platelet Activating FactorIBA
01/2023 - 06/2021
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2022 - 02/2018
2PlatinumIBA
01/2022 - 10/2020
2Retinoid X Receptors (Retinoid X Receptor)IBA
01/2022 - 01/2017
2dostarlimabIBA
11/2021 - 07/2021
2pembrolizumabIBA
11/2021 - 07/2021
2human ERBB2 proteinIBA
08/2021 - 01/2020
2RNA (Ribonucleic Acid)IBA
08/2021 - 03/2013
2Trace amine-associated receptor 1IBA
08/2021 - 09/2017
2Prostaglandin Receptors (Prostaglandin Receptor)IBA
03/2021 - 01/2018

Therapy/Procedure

34Therapeutics
09/2023 - 06/2003
9Drug Therapy (Chemotherapy)
08/2023 - 01/2009
5Mastectomy (Mammectomy)
01/2016 - 11/2008
4Immunotherapy
12/2019 - 06/2009
3Breast Implants (Breast Implant)
08/2023 - 04/2013
3Radiotherapy
08/2023 - 11/2008
3Neoadjuvant Therapy
10/2022 - 06/2011
2Adjuvant Chemotherapy
08/2022 - 06/2011
2Ligation
01/2021 - 01/2019